Barclays’s Kindred Healthcare KND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-325,463
| Closed | -$2.93M | – | 7682 |
|
|
2018
Q2 | $2.93M | Sell |
325,463
-820
| -0.3% | -$7.35K | ﹤0.01% | 2201 |
|
|
2018
Q1 | $2.99M | Buy |
326,283
+22,213
| +7% | +$206K | ﹤0.01% | 2072 |
|
|
2017
Q4 | $2.95M | Buy |
304,070
+286,082
| +1,590% | +$2.13M | ﹤0.01% | 2084 |
|
|
2017
Q3 | $122K | Sell |
17,988
-20,873
| -54% | -$178K | ﹤0.01% | 4793 |
|
|
2017
Q2 | $453K | Sell |
38,861
-115,270
| -75% | -$1.14M | ﹤0.01% | 3626 |
|
|
2017
Q1 | $1.29M | Buy |
154,131
+129,158
| +517% | +$1.01M | ﹤0.01% | 2497 |
|
|
2016
Q4 | $195K | Sell |
24,973
-87,340
| -78% | -$717K | ﹤0.01% | 4234 |
|
|
2016
Q3 | $1.15M | Buy |
112,313
+3,877
| +4% | +$43K | ﹤0.01% | 2498 |
|
|
2016
Q2 | $1.22M | Buy |
108,436
+105,677
| +3,830% | +$1.32M | ﹤0.01% | 2435 |
|
|
2016
Q1 | $33K | Sell |
2,759
-1,127
| -29% | -$11.7K | ﹤0.01% | 5006 |
|
|
2015
Q4 | $42K | Sell |
3,886
-104,296
| -96% | -$1.35M | ﹤0.01% | 4901 |
|
|
2015
Q3 | $1.63M | Buy |
108,182
+106,553
| +6,541% | +$2.16M | ﹤0.01% | 2299 |
|
|
2015
Q2 | $33K | Sell |
1,629
-101,122
| -98% | -$2.32M | ﹤0.01% | 5407 |
|
|
2015
Q1 | $2.36M | Sell |
102,751
-152,124
| -60% | -$3.09M | ﹤0.01% | 2152 |
|
|
2014
Q4 | $4.59M | Sell |
254,875
-32,810
| -11% | -$649K | ﹤0.01% | 1780 |
|
|
2014
Q3 | $5.47M | Buy |
287,685
+132,983
| +86% | +$2.9M | 0.01% | 1696 |
|
|
2014
Q2 | $3.56M | Sell |
154,702
-23,681
| -13% | -$579K | ﹤0.01% | 2063 |
|
|
2014
Q1 | $4.1M | Sell |
178,383
-46,553
| -21% | -$963K | ﹤0.01% | 1864 |
|
|
2013
Q4 | $4.27M | Buy |
224,936
+34,045
| +18% | +$549K | ﹤0.01% | 1955 |
|
|
2013
Q3 | $2.48M | Buy |
190,891
+27,688
| +17% | +$398K | ﹤0.01% | 2337 |
|
|
2013
Q2 | $2.14M | Buy |
+163,203
| New | +$1.95M | ﹤0.01% | 2480 |
|
Barclays's KND Position: Q3 2018 in Review
Barclays sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 325,463 shares — an estimated $2.93M sold.
Barclays first reported a position in KND in Q2 2013 and held it in 21 quarters. The position peaked at $5.47M in Q3 2014. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.
- Barclays reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
- Barclays sold 325,463 Kindred Healthcare shares in Q3 2018, an estimated $2.93M.
- Barclays first reported a position in Kindred Healthcare in Q2 2013 and held it in 21 quarters.
- Barclays's Kindred Healthcare position peaked at $5.47M in Q3 2014.
- 0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.